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Renal papillary necrosis is a disease entity that has
been recognized since 1878. Today, one hundred years later,
a considerable amount of knowledge has been gathered about its
possible etiologies, associated conditions, pathological pic
ture, clinical manifestations, radiological features and mode
of treatment. Very little is known, however, about prognosis
of this disease. The literature is deficient of prognostic
studies that may help the clinician predict the course of
patients with renal papillary necrosis.
This study is aimed to provide some answers to questions




Review of the Literature
It was one hundred years ago that Von Friedreich contributed
to the medical literature the first description of a case of
renal papillary necrosis (84). That first case was observed in
association with urinary tract obstruction and hydronephrosis.
Since then, this disease entity has been associated with a number
of conditions that include most commonly diabetes mellitus,
sickle hemoglobinopathies, analgesic abuse and urinary tract
obstruction. Most recently the list has been extended to include
chronic alcoholism, cirrhosis of the liver, rheumatoid arthritis,
ankylosing spondylitis in association with prostaglandin synthe
tase inhibitors, renal vein thrombosis, renal tuberculosis, a-
plastic anemia, post gastroenteritis and severe dehydration in
infants, histoplasmosis and hypercalcemia with renal failure,
and post kidney transplants. It has been reproduced experimentally
with agents such as bromoethylamine hydrobromide.
Renal papillary necrosis is generally defined as "an
ischemic necrosis involving the renal medulla, which in the ab
sence of localizing, obstructive or vascular factors is usually
bilateral and most often associated with infection"(28). Although
most investigators are constantly disagreeing with each other
about certain issues of pathogenesis and natural history in this
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disease, virtually all investigators agree with the first part
of this definitionpapillary necrosis follows after a vascular
lesion has occurred in the renal medulla that compromises the
blood supply of the vasa recta. Mechanisms of embarrassment of
blood supply in the medulla have been suggested for each of the
associated conditions.
There are authors who believe renal papillary necrosis
probably represents a variant of pyelonephritis (28, 56, 57).
Lauler et al in 1960 presented six case reports and then point
out infection as a common denominator (57). Lalli, in 1972,
after studying fourteen patients from the Cleveland Clinic who
had diabetes mellitus, analgesic abuse, obstructive uropathy and
chronic and acute pyelonephritis as contributing factors, observed
that urinary tract infection was the most important common finding
in his patients (56). Friedenberg states that in patients with
papillary necrosis "pyelonephritis is probably the prime etiologic
factor, and it is presumed that infection with bacterial prolif
eration and necrosis leads to decreased blood flow and ischemia"
(28). In 1967 Kincaid-Smith , however, showed that papillary
necrosis is the primary lesion in the kidney of rats that abuse
analgesics (52). Whether papillary necrosis can be taken to repre
sent a variant of pyelonephritis or not is not a crucial issue.
More relevant to the clinician should be the fact that the late
stages of papillary necrosis may be indistinguishable from chronic

-9-
pyelonephritis, as was pointed out by Harrow, who also stresses
the importance of identifying the disease early in its course (36).
The pathological lesion in papillary necrosis has been studied
with considerable detail. Generally there is a sharp demarcation
between necrotic and viable tissue which suggests necrosis
due to ischemia. Papillary necrosis is not just an inflammatory
process. It is important to point out that the lesion is truly
a necrotic one, where the tissue is no longer functional.
Davies et al have described three different types of histologic
lesions: a large central area of necrosis clearly demarcated
from surrounding tissues by a band of leucocytes; a small well
demarcated lesion involving the tip of the papillae and a band
sclerotic lesion with an indefinite margin (18). Whether there
is something specific in the pathogenesis of this disease that
determines the type of histologic lesion is not known.
Lagergren et al studied the intrarenal arterial tree in
kidneys of patients with papillary necrosis and chronic pyelon
ephritis using parallel stereo-microangiographic and histologic
techniques (55). They found that in the pyramids with fresh
papillary necrosis the postglomerular vessels of juxtamedullary
glomeruli were not visualized probably due to constriction of
the vessels by periglomerular fibrosis. They postulate that if
the adaptation of other arteriolae rectae to collaterals fail to
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occur, papillary necrosis develops. Harrow entertained the
hypothesis of an antigen antibody reaction accounting for vascu
lar blockage which eventually leads to the lesion of papillary
necrosis (37). Finally, for each of the conditions that have
been associated with this renal lesion, a mechanism of meduallary
vascular insufficiency has been hypothesized and many of these
are accepted by most investigators as possible in the pathogenesis
of the lesion. We will mention these when we consider the liter
ature on each of these associated conditions.
In the last forty years the association of papillary necrosis
and diabetes mellitus has been noted many times by different
observers. As with the other associated conditions, the indidence
of papillary necrosis in diabetes varies with the observer. Harrow
reports an 18% incidence in long standing diabetics (36). Prior
to 1950, as much as two thirds of all patients with papillary
necrosis were diabetics and the remaining third had suffered
from obstruction. More recently, most reports note a lower
percentage of diabetics, probably due to the wider recognition
of this disease as associated with many other conditions together
with improvement in diagnostic skills.
The pathogenesis in diabetics is generally accepted to be
small vessel disease--arteriolar and arterial sclerosis. In
creased vulnerability to infection, increased infection rate and




formation are also considered contributing factors. Wright, in
his paper on an eight year survival of a diabetic with papillary
necrosis, lists the autopsy findings: end stage kidneys with
hyalinization and fibrosis of glomeruli, dilation of tubules,
glomerulosclerosis, arterionephrosclerosis and chronic pyelon
ephritis (88). He observed no active papillary necrosis but
instead, incomplete loss of papillae bilaterally. This descrip
tion gives us some good insight into the pathology of the diabetic
kidney with papillary necrosis. The reputation of diabetes as
having the worse prognosis among the different conditions associ
ated with papillary necrosis (1,39,88) probably stems from the
observations that the pathology of such kidneys includes more than
just necrosis of pyramid tips, but also other renal injuries such
as chronic pyelonephritis, arteriolonephrosclerosis and glomeru
losclerosis, sometimes leading to end stage kidneys with loss of
vital renal function. The cause of death of this particular
patient was a right cerebral infarct.
Among the few investigators that have reported on favorable
followups of diabetics with papillary necrosis, stands Hugo who
presents a case of a diabetic with papillary necrosis diagnosed
by histology on tissue passed in the urine who was maintained
assymptomatic on bacteriostatic antibiotic therapy with some brief
intermissions for sixteen months (44). Nevertheless, the literature




have papillary necrosis is a rare event. Abdulhayoglu, for
example, reported in 1964 a study on fourteen such patients of
which 13 had died in an eight year periodfour of diabetic
nephropathy (1). Few of the patients in his study had signifi
cant relevant symptoms at diagnosis but most developed character
istic symptoms before death.
Patients who have an S-hemoglobinopathy as an associated
condition to papillary necrosis are said to be indistinguishable
from patients with other etiologies both radiological ly and
clinically (24, 38). Renal papillary necrosis has been observed
in patients with SS, AS and SC disease, but hematuria has been
reported most frequently in patients with AS hemoglobin (21).
Various types of papillary abnormalities are seen in as much as
50% of patients with AS hemoglobinopathy (24). Vix reported the
first case of a patient with SC hemoglobin and papillary necrosis
in 1965 (83). Most likely, the fact that most cases of papillary
necrosis have been observed in association with AS hemoglobin
rather than with SS or SC is linked to the incidence of the AS
disorder itself which is much higher than the SS or SC types
(HbSS: HbAS = 1:40).
The most popular mechanism of pathogenisis for sicklers
with papillary necrosis is as follows: in the renal medulla
factors of high osmolality and low oxygen tension predispose to
sickling of red blood cells which occurs in the vasa recta blocking

-13-
the blood supply and making the countercurrent mechanism fail
which results in hyposthenuria and the anatomical lesion of
papillary necrosis (83). Pitcock et al , however, reported a
study on early renal changes of patients with SS disease in 1970
on which they show that the lesion is not simply the result of
ischemia (75). They studied kidney biopsies of patients with
SS disease and hyposthenuria using both light and electron micro
scopes and noted changes not specific for sickle cell diseasecon
gested glomeruli, minor alterations of foot processes and basement
membraneswhich were less evident than changes seen in patients
with clinical renal disease but more evident than in normals.
Whether these early changes in the kidney of the patient with
sickle disease are also a result of transient ischemia is not
known but certainly possible.
Much has been written about analgesic abuse and its association
with renal papillary necrosis and chronic insterititial nephritis.
It is a subject matter that has caused much controversy among
different investigators that have come up with opposite answers
for some basic questions such aswhich is the analgesic con
stituent responsible for the renal damage?, what is the mechanism
of pathogenesis involved?, is prognosis really good for those
analgesic abusers that abstain once they have some renal damage?.
Unfortunately, the onset of papillary necrosis in analgesic
abuse appears to be determined by complex combinations, and no
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simple cause-effect relationship has been established for this
condition. This apparent complexity begins with the vast number
of agents that have been postulated as candidates responsible
for causing papillary necrosis: aspirin, phenacetin, N-acetyl-
p-aminophenol (APAP, paracetamol), caffeine, amidopyrine, phen-
azone, phenylbutazone and chemical contaminants in some prepara
tions. Most of the controversy, however, appears to be between
those believing ASA is responsible (8,10,29,31,51,71,73,77) and
those who blame phenacetin for the renal lesion (14,49,64,74).
It has been noted that in North America, the disorder has been
associated almost entirely with heavy ingestion of combination
products of ASA, phenacetin and caffeine (29). Although there
seems to be less clinical and experimental evidence for the
nephrotoxicity of single analgesics as compared to that caused
by combination drugs, the evidence for renal damage caused by
ASA alone is much greater than that for phenacetin alone (29,
51,71,73). Nanra and Kincaid-Smith were able to produce pap
illary necrosis in seven out of 19 rats given aspirin alone,
whereas phenacetin alone failed to cause any renal damage over
six to nine months (73). Murray, who studied analgesic nephro
pathy in 86 patients, observed that 84 patients had abused mix
tures containing both ASA and phenacetin, but still note renal
papillary necrosis in two patients that had abused aspirin
alone (71). Prescott presents another case of a patient with
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papillary necrosis who used to ingest seven tablets of ASA per
day for three years and who took no preparation containing phena
cetin (77). He also suggests that nephrotoxicity has been falsely
attributed to phenacetin and that the salicylate usually taken
with the phenacetin could ^/ery well be responsible for the renal
injury. One year ago, Berg et al showed that with increasing plasma
levels of ASA there is a decrease in sodium excretion, a dose re
lated decrease in paraaminohypuric (PAH) clearance, and no change
in creatinine clearance (18). He implies that ASA inhibits tubular
transport mechanism, at least for PAH transport and that the effect
of ASA on renal blood flow and sodium excretion may be related
to its inhibitory effect on prostaglandin synthesis.
On the other hand, Bluemle et al showed that there is no
medullary gradient for salicylate in dehydrated or hydrated dogs
whereas there is one for paracetamol, a metabolite of phenacetin,
which varies with hydration (10). This kind of evidence points
out to phenacetin as responsible for analgesic nephrotoxicity
implying the renal accumulation of a toxic metabolite. The author
emphasizes that adequate hydration may provide protection in
patients who abuse analgesics. However, phenacetin was first
implicated in analgesic nephrotoxicity on the basis of being a
"common denominator" in most mixtures of analgesics abused by
patients that later on developed nephrotoxicity. "This kind of
reasoning is reminiscent of the scientist, who, having become in-
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toxicated on successive occasions from drinking scotch and
soda, bourbon and soda and rye and soda concluded that soda was
inebriating" stated Gilman in his editorial in 1964 (31). Kasanen
observed that after restriction of the sale of phenacetin in Fin
land the incidence of papillary necrosis established at autopsy
fell from 8.9% to 3.8%. Furthermore, the alternative of both
ASA and phenacetin having additive effects in the pathogenesis
of analgesic nephropathy and papillary necrosis should also be
considered.
The magnitude of the analgesic abuse problem in this country
has not been studied accurately, but it is certainly not as common
as in foreign countries like Australia and Sweden. Kincaid-Smith
states in 1969 that papillary necrosis, the primary lesion of
analgesic nephropathy, is 50 times as common in Australia as it
is in the United States. Clinical features usually include un
explained renal dysfunction (hyposthenuria, elevated serum creat
inine), radiological changes (which include papillary necrosis
in situ, ie. , without sloughing), sterile pyuria (considered by
Dawborn the most frequent urinary finding) and urinary tract
symptoms (19,22,61,76). Hare points out that missed diagnosis
probably results from lack of awareness of the clinical context
of the disease, failure to display calyceal detail in pyelography
and ignorance of the frequency of the necrosis in situ typethe
other types being total papillary sloughing, which leads to club-
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bed calyces, and partial papillary sloughing, which leads to
papillary cavities (35).
Kincaid-Smith presented pathological, clinical and
radiological data to support her hypothesis for the pathogenesis
of the lesion in analgesic abuse: papillary necrosis is the
primary lesion and probably results from precipitation of ex
cretion products of analgesic drugs in the highly osmolar medulla;
cortical changes are a result of atrophy which develops as a
consequence of papillary necrosis (52). Papillary necrosis in
analgesic abuse is once again believed to be secondary to an
interruption of blood supply in the vasa recta (3,50,53). In
vestigators like Pribe and Barraclough have discussed mechanisms
by which phenacetin may cause papillary necrosis: paracetamol is
concentrated in the papillae as a result of the countercurrent
supply of blood, probably inhibits cellular enzymes, causes
methemoglobinemia, or has a direct toxic effect leading to anoxia
or ischemia of the papillae (6,78). Hypersensitivity reaction
and the effect of shortened life span of red blood cells have
been other possibilities entertained (31). Last year, Abrahams
noted changes of hyalinization of vessels in the submucosa of
bladder tissue, pelvis, ureter and renal medulla in patients
with analgesic nephropathy (4). The suggestion was made that
these vascular changes may play an important role in the de
velopment of papillary necrosis.
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The prognosis in analgesic nephropathy is believed to be
good if the drugs are stopped (7,9,51,61,71,80,86). Murray
notes that renal function continues to deteriorate if only phen
acetin is stopped and ASA continued (71). Linton and Murray
have observed that prognosis is favorable even when significant
renal failure has already occurred (61,71). Somewhat less opti
mistic are Wilson and Bell who besides noting significant improve
ment in some of the patients, followed some who developed terminal
renal failure and others that had static or slowly declining re
nal function (7,86). However, all agree that the likelihood of
improvement is increased with cessation of abuse.
Finally, a series of reports are found in the literature
which make reference to the analgesic abuse syndrome-analgesic
abuse, analgesic nephropathy and peptic ulceration (19,23,30,70,
71). Hypochromic anemia (from GI losses), hypertension, psy
chosocial disorders, and signs and symptoms of papillary necrosis
have all been associated with this clinical picture. Murray
points out that patients who abuse analgesics are more likely to
have a family history of drug abuse and show some evidence of
personality disorder or neurosis (70). These patients are al
so prone to abuse other drugs and smoke excessively. Emphasis
should be placed in the recognition of this clinical presentation.
The association of rheumatoid arthritis and renal papillary
necrosis is based on the therapy. Aspirin and phenacetin are

-19-
again the agents most mentioned as responsible for the renal damage.
Bulger et al studied 42 patients with rheumatoid arthritis and
noted renal abnormalities in 22 (13). The only two patients that
took phenacetin did not have renal disease and only one patient
had not taken large doses of aspirin as therapy for rheumatoid
arthritis. Aspirin is again implied here. On the other hand,
Burry et al , Mack! on et al , and a New Zealand Rheumatism Associ
ation Study all assume the position of defendants of aspirin in
the treatment of rheumatoid arthritis, stating that aspirin rarely
if ever causes analgesic nephropathy when prescribed and taken
appropriately for the treatment of rheumatoid arthritis (14,64,
74). Clausen noted an increase in the incidence of papillary
necrosis in the autopsies of patients with rheumatoid arthritis
in Denmark from the period of 1951-56 to the period of 1957-60
and attributes this to an increase of phenacetin use in Denmark
during that time period (16).
We have already discussed chronic pyelonephritis as some
authors consider papillary necrosis a variant of this more general,
ill defined condition. One of the problems of establishing chronic
Pyelonephritis as an associated condition is that the term is
not yet clearly defined and clinicians, radiologists and bacteri
ologists all apply different criteria to its diagnosis (12).
Mellins, in this respect, gives us a descriptive paper on chronic
pyelonephritis and renal papillary necrosis and makes a good
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attempt to define chronic pyelonephritis (67). Case reports of
papillary necrosis have been presented, however, where chronic
pyelonephritis is the only associated condition (42). Although
infection might very well be secondary to papillary necrosis in
stead of being a causative agent, the mechanism of inflammation
and edema occluding the vasa recta is generally accepted (28).
Urinary tract obstruction may lead to the lesion of papillary
necrosis (84,32). It is though closely linked to chronic pye
lonephritis as an associated condition and likewise, it is many
times difficult to determine if obstruction is secondary to pap
illary necrosis (a sloughed papilla may cause obstruction of a
ureter) or indeed a causative factor. Harrow reported that there
was no increased incidence of papillary necrosis among cases of
obstructed ureters (37).
In a prospective study of patients with radiological pyelo
nephritis, papillary necrosis and obstructive atrophy, Grower ob
served a five year survival rate (calculated) of 92% for patients
with renal papillary necrosis and a 10 year survival rate of 56%
(32). The study indicated a benign course for most patients with
radiological pyelonephritis. Another interesting finding was
that bacteriuria was not associated with deteriorating renal
function.
Lourie et al have reported this year on the association of
renal papillary necrosis and ankylosing spondylitis (63). All
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three patients had received prostaglandin synthetase inhibitors
(phenylbutazone, indomethacin, ibuprofen) and the authors postu
late that these drugs could have an adverse effect on the blood
flow of the renal medulla. A renal vascular lesion related to
the ankylosing spondylitis could possibly play a role in patho
genesis here. Also, one of the three patients had AS disease.
Longacre et al have noted cirrhosis of the liver as an
associated condition of papillary necrosis (62). The pathogenesis
implied here is that the increased total renal vascular resistance
noted in patients with cirrhosis reflects renal vasoconstriction
with reduced renal blood flow. Thus, ischemic necrosis of the pap
illae can result from this vasoconstriction and/or thrombosis of
the vasa recta. They also note that cirrhotic patients with renal
dysfunction share some consistent features such as inability to
excrete sodium adequately, hyposthenuria and increased total renal
vascular resistance.
Edmondson et al reported on the association of chronic alchoholism
and papillary necrosis (25). They studied 20 patients with chronic
alcoholism (16 of these 20 had fatty change or cirrhosis of the
liver or both) and papillary necrosis out of a total of 195 patients
with papillary necrosis. At necropsy, all of these patients
had
acute pyelonephritis, 12 had cortical abscesses, and 12 had a-
cute cystitis. Their hypothesis for pathogenesis is that the al
coholic is more vulnerable to infection.
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Several reports are included in the literature on the association
of papillary necrosis and post gastroenteritis and severe dehydra
tion in infants (5,15,45). Dehydration has been implied as play
ing a most important role in pathogenesis here. Prognosis differs
with different reports. Chrispin, for example, notes that renal
damage by follow-up IVP's is permanent in these kids and indistin
guishable from chronic pyelonephritis (15). Husband, on the other
hand, notes a slightly better prognosis than Chrispin one of his
two infants had normal renal growth nine months after the a-
cute episode by IVP whereas the other one could not concentrate
the urine still at nine months. Renal tubular necrosis was also
noted following severe gastroenteritis and dehydration in these
infants.
Wind et al present a case report of a patient with aplastic
anemia and papillary necrosis (87). That particular patient died
of septicemia and autopsy findings included papillary necrosis,
hemosiderosis, and aplastic anemia. The authors state that there
is no experimental evidence leading to the association of heavy metal
deposition and papillary necrosis. Thus they attribute the renal
lesion to the aplastic anemia, again implying ischemia in the path
ogenesis.
Walker et al report on a 56 year old man with histoplasmosis,
hypercalcemia, renal failure and papillary necrosis (85). The




Renal vein thrombosis constitutes another rare associated
condition of papillary necrosis. Swartz et al noted that two out
of his seven examples of renal papillary necrosis had renal and
intrarenal vein thrombosis as well (81). Trauma with shock (81)
and renal tuberculosis (56) must also be mentioned for the sake of
completeness.
Papillary necrosis has also been noted in transplanted kidneys
(26,59,82). It is believed that the lesion here is part of the a-
cute rejection process. The hypothesis is that immediate formation
of microthrombi in the vasa recta leads to papillary ischemia.
This year a case report of a patient with an aberrant renal
papilla appeared in the literature (54). The patient was assymp
tomatic, had negative laboratory tests but an abnormal IVP. A
retrograde showed abnormal renal papilla mimicking papillary necro
sis. Although this is a rare case, the clinician must be aware
and observation should be the treatment of choice.
The lesion of renal papillary necrosis has been reproduced
experimentally by a variety of agents including analgesics, vinyl-
amine, bromethyl amine hydrobromide (BEA) and human serum. These
experiments further confirm that complex mechanisms probably op
erate in the pathogenesis of this renal lesion. Murray, Wyllie,
Hill et al studied the mechanism of BEA induced papillary necrosis
(43,69). They noted that the earliest changes to occur are necrosis
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of limbs of Henle and eosinophilic droplets in the collecting
ducts. They could not demonstrate organic blockage of the vasa
recta or capillaries and noted that changes in the vasa recta
occur simultaneously with tubular changes. Later on they make the
observation that vasoconstriction plays an important role in path
ogenesis since reserpine, which depletes catecholamines, had an
inhibitory effect on the development of the lesion. Ham and Tange
reported on vinylamine induced papillary necrosis (34). They
used carbon labelling to detect circulation at different stages
of the lesion. They conclude that direct tissue injury and venous
circulatory statis are most important in pathogenesis. The ex
periments with analgesics by Kincaid-Smith have already been men
tioned in the section of analgesic abuse.
Mery little is found in the literature regarding prognosis
of this disease. What is known about prognosis is mostly in con
nection to the analgesic abuse condition and this has already been
mentioned. We also pointed out the bad reputation of diabetes in
terms of prognosis, and the five year and 10 year survival rate
noted by Gower (32). There is no comprehensive prognostic study
found in the literature that considers all the associated conditions
in the determination of prognosis.
A few papers appear in the
literature on the subject of
treatment, mostly in reference to the surgical and urological man




aim at the correction of the associated condition (ie. , stop
analgesic abuse), treating infection when it is present and
symptomatic treatment. Catheter drainage, open surgical pro
cedures and even unilateral nephrectomy may become necessary to




In this study, the hospital charts of 62 patients with
renal papillary necrosis were obtained from the Department of
Medical Records of the Yale-New Haven Hospital and reviewed.
This group of patients was selected from two sources: A- a
larger group of 321 patients carrying a diagnosis of pyelonephritis
provided by the Medical Records coding system, seen in the years
1969 to 1972, which was then screened for cases of papillary necro
sis; and B- a group of patients with positive radiographic changes
whose names and unit numbers were provided by Dr. Arthur Rosen-
field, radiologist. Nineteen patients were accepted for the study
after screening the large number of patients coded under pyelo
nephritis in the years 1969-1972. The other 43 patients belong to
the subgroup provided by the radiologist and whose dates of
diagnosis range from 1963 to 1977. All patients included
in this
study had renal papillary necrosis as diagnosed by positive
radio
graphic changes or pathologic description. Our group
is by no
means a complete group since we did not intend to include
all
cases of papillary necrosis diagnosed in the last
fifteen years.
Neither is our group randomized because of the way
that the patients
were selected. However, we believe our group of patients represent
a large adequate series for the study
of the clinical features of




mentioned limitations of patient selection and unnecessary and
inaccurate comparisons to the general population were avoided.
The study was undertaken in a retrospective way and an attempt
to update information was included. Limitation of time prevented
a prospective study, which could have had the advantages of better
control in patient selection, completeness of the patient popula
tion, uniformity of valuable information obtained, and most im
portant, adequate follow-up for most patients.
A retrospective check list was prepared for the chart review,
and it is included here as Appendix 1. Its format was designed for
easy transfer of information into IBM computer cards. Thus all
answers in our questionnaire are recorded as digits from 0 to 9
in each space, and each space is numbered and corresponds to
an IBM computer card location. Each card can hold 80 such loca
tions and our questionnaire took a total of five cards to accommodate
all the information.
The following items were looked for in each chart and recorded
in the retrospective check list: demographic data (sex, ethnic
origin, age); is the patient dead or alive? and cause of death;
associated conditions (diabetes mellitus, sickle hemoglobinopathies,
analgesic abuse, urinary tract obstruction, chronic pyelonephritis,
renal vein thrombosis, alcoholism and cirrhosis); significant
medical history (including psychiatric history, hypertension,




diagnosis; findings of urinalysis, BUN, serum creatinine and
signs and symptoms at diagnosis and every year after for five
years; and modality of treatment employed. A section for current
status is included as the last page of the check list. Part I
of this section concerns an update of signs and symptoms. For
this purpose a questionnaire and an informed consent form was
sent to those living patients whose addresses were available from
their charts. Of the 52 letters sent, seven questionnaires were
returned completed, three were returned because the patients were
now deceased and 12 were returned because they were undeliverable
as addressed. Our attempt to obtain an update of information in
our group of patients was not very successful.
A section for radiographic changes was provided in our
retrospective check list and concerned mostly the IVP or retro
grade description at diagnosis and every year after for five years,
the question of unilateral or bilateral involvement and the number
of calyces involved. The descriptions of radiographic studies
included in the charts were found to be insufficient in providing
the desired information about the radiological findings in this
disease. A more extensive and careful survey of the radiographic
studies that these patients underwent is being conducted simultaneous
ly by Dr. Arthur Rosenfield. The check list is similar in format
to the one used in this study and its data should be easily pro
cessed and correlated with our findings by the computers, once the
/
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information is passed to IBM computer cards.
The data gathered from our 62 patients was transferred to
computer cards by the A&M Keypunching Services of Yale Computer
Center. The program for handling and processing the data was




Since this study belongs in the category of non-experimental,
descriptive research, statistical tests of significance were not
felt to be helpful and, thus, are not included (46). Computer
analysis made two-dimensional correlation a relatively easy pro
cedure. Thus, we provide here means and frequency distributions
for most variables as these correlate to the entire group of
62 patients and to the patients grouped by associated conditions.
Finally, we looked into cross-correlations between some variables
and patients with distinctive, interesting features (ie., hy
pertensives, cigarette smokers, patients with history of urin
ary tract infection).
Table 1 displays the data that describes our patients
demographically in terms of age (including mean age at diagnosis,
median age and range), sex and ethnic origin.
We found we could group our 62 patients by associated
conditions in two different ways: A- where each patient had
only one associated condition, and if the patient had more than
one he was placed in the "mixed etiologies" group (distribution
of patients in this manner is81% (5) diabetics alone, 9.7%
(6) S-hemoglobinopathy patients, 1.6% (1) analgesic abuser,
9.7% (6) urinary tract obstruction patients, 3.2% (2) chronic
pyelonephritis patients, 0.0% (0) alcoholics, 0.0% (0) cirrhotics,
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freq. distrib a tien
39.9 37 .0 10-18 3 0.6%
t ion
69.4% 48.41 4 8.4% 3.2%
21.0 20. 5 20-22 - 100% 100%
-
-
56.1 57.0 47-65 33.3% 66.6%
66.6% 33. 3%
-
41.5 39.0 37-46 5 0% 50%
- 100% -
36.6 29.0 21-63 21.4% 78.6%
- 100% -
20. 5 20. 5 20-21 50% 5 0%
- 100% -
39.1 42.5 20-52 16. 7% 83. 3% 66.7% 3 3.3% .
-
47 .8 45.0 26-70 42 .9% 5 7.1% 42.9% 57 .1%
-
47 .6 48.0 21-82 29.4% 70.6% 5 8.8% 29.4% 11.8%
40.2 36.5 10-65 3 3.3% 6 6.7% 75.0% 25. 0%
-
42.0 45.0 10-82 28.6% 71.4% 76.2% 19. 0% 4 .8%
48.6 46.0 36-63 57.1% 42.9% 14.3% 8 5.7%
-
47 .2 45.5 36-58 75.0% 25.0% 25.0% 75.0%
-
21.0 21.0
_ . -__ 100% 100%
- -




mixed etiologies patients); and B- where patients were counted
by number of times they appeared associated with a specific
condition regardless of existence of other conditions for the
same patient same patients are thus included in different
groups (distribution of patients in this manner is 17.7% (11)
diabetics, 29.0% (18) S-hemoglobin patients, 21.0% (13) anal
gesic abusers, 46.8% (29) UT obstruction patients, 34.4% (21)
chronic pyelonephritis patietns, 11.3% (7) alcoholics, 6.4% (4)
cirrhotics, 1.6% (1) renal tuberculosis patient). Due to the
large number of patients with mixed associated conditions and
consequently the small number of patients that have only one
associated condition we chose to use the latter method of group
ing the patients for all other correlations.
Data collected as significant medical history for all 62
patients showed the following frequency distributions for diseases:
cancer 8.1%, tuberculosis 4.8%, stroke 1.6%, neurologic disease
21.0%, other renal disease 14.5%, heart disease 17.7%, liver
disease 8.1%, lung disease 16.1%, GI disease 21.0%, collagen
vascular disease 0%, allergies 14.9%, psychiatric history 21.0%
(13 patients, 11 of which had depression).
Of the 62 patients, only 13 or 21.0% were found to be hy
pertensives (10 with diastolics
between 90 and 100, two between
100 and 110 and one between 110 and 140). Mean systolic pressure




pressure was 80 mmHg.
Forty-six percent (27) of patients did not smoke cigarettes,
while 24.1% (14) were considered light smokers (less than one
pack/day for more than one year) and 29.3% (17) were considered
heavy smokders (more than one pack/day for more than one year).
Sixty-nine percent (43) of all patients had a history of
urinary tract infection. E. Col i was the organism found in 16
patients, Klebsiella species in three patients, Proteus species
in three patients, Gram + cocci in 1, mixed organisms in six,
other organisms in three. Forty-seven percent (29) of all patients
were actually found to have a urinary tract infection when the
diagnosis of papillary necrosis was made.
Diagnosis was made by intravenous pyelography in 77.4%
(48) of patients. Six patients 9.7% were diagnosed with a retro
grade urographic exam. In five patients8.1% diagnosis was
stated in a pathological report at nephrectomy. In one patient
diagnosis was made when a sloughed papilla was removed
at sur
gery. In another patient diagnosis was
made with the aid of a
selective arteriogram. Still in another patient the diagnosis
is stated in the surgeon's post-op note. None of the patients
were diagnosed by tissue passed in the urine
or at necropsy.
Findings at diagnosis were certainly compatible
with criteria
for diagnosis renal papillary necrosis
in 79.0% (49) of all




Sixty-four percent (40) of all patients had unilateral
involvement while 35.5% (22) had both kidneys involved. By
associated conditions: diabetics 81 .8% unilateral, 18.2%
bilateral; S-hemoglobin 50% unilateral, 50% bilateral; anal
gesic abusers 61.5% unilateral, 38.5% bilateral; UT obstruction
patients 69.0% unilateral, 31.0% bilateral; chronic pyelo
nephritis 61 .9% unilateral, 38.1% bilateral; alcoholics 57. 1%
unilateral, 42.9% bilateral; cirrhotics 75% unilateral, 25%
bilateral; the one patient with renal Tb had unilateral involve
ment.
Seventy-seven percent (48) of all patients received treatment
for their renal papillary necrosis: 67.7% (42) antibiotics
(29.0% Ampicillin, 17.7% Gentamicin, 16.1% a cephalosporin,
12.9% Gantirisin, 33.9% other); 40.3% (25) fluids; 17.7%
(11) ureteral catheterization; 27.4% (17) surgery and 3.2%
(2) dialysis.
Nineteen percent (12) of all patients are known to be dead.
Mean years of follow-up since diagnosis for all patients was
5.2
years, median4.0 years, range
0-14 years. Seven patients died
of extrarenal causes (CVA, MI), one patient died in severe renal
failure, four patients died of undetermined causes. Distribution
of deaths among the associated conditions can
be appreciated in
Table 2.




termined by mean serum creatinine at initial presentation and
at years 1,2,3,4, and 5 after diagnosis.
Tables 4 and 5 display findings of urinalysis: Table 4
for all patients at initial presentation and at years 1,2,3,
4 and 5 after diagnosis; and Table 5 for all patients and
for patients grouped by associated conditions at initial presenta
tion only.
Tables 6 and 7 are similar to Tables 4 and 5 but they
present findings of signs and symptoms instead.
For the hypertensives, their mean age was 47.6 years;
69.2% of them were females, 30.8% were males; 46.2% were White,
46.2% were Black and 7.6% Hispanic. Only one hypertensive patient
is known to be dead and died of an extrarenal cause. Sixty-one
percent of hypertensives smoked cigarettes and 84.6% had a history
of urinary tract infections. Their mean serum creatinine at
diagnosis was 2.3 mg/dl as compared to 1.6 mg/dl for the normo-
tensive subgroup. Their mean serum creatinine for the years
following diagnosis varies from 1.2 mg/dl to 1.4 mg/dl for years
1 to 4 after initial presentation (n less than 5 for all years)
and rises to 3.8 mg/dl (n=2) five years after diagnosis. At initial
presentation, 61.5% (8) of patients had pyuria,
none had glucosuria,
30.8% (4) had proteinuria, 30.8% (4) had hematuria by U/A,
76.9%
had bacteriuria, mean pH was 6.0, and mean specific gravity was









































Table 2. Percentage of Patients known to be Dead:
All patients, patients grouped by Associated Conditions


























1.8 (49) 1. 9 (20) 1.4 (9) 2.3 (7)
3.1 (7)
1.5 (1) 1. 7 (1) 1.6 (1)
- 3.2 (1)
2.2 (9) 4.0 (4) 2.0 (1)















2.6 (4) 3.5 (3) 1.9 (2)
-
- 1.3 (1)




2.6 (14) 1.4 (5) 1.6 (2) 3.1 (3) 1.2 (2) 1.6 (3)
1.8 (10) 2 .8 (4) 1.6 (3) 1.6 (1)
- -
2 . 0 (20) 3.0 (7) 1.8 (4) 2.7 (5) 1.7 (3) 3.9 (4)
1.4 (6) 1.3 (3) 1.2 (3)
- - -







Table 3. Renal Function at Diagnosis and at 1,2,3,4 and 5 years after diagnosis for





















































































Table 4. Findings of Urinalysis at Diagnosis and at 1,2,3,4 and 5
years after diagnosis for all
Patients. (Pyuria = any in males,
5 wbc's in females, glucosuria
= ^ 1+ , proteinuria
= > 1+
,












Pyuria , Glucos- Protein- Hema-
































































































Table 5. Findings of urinalysis at Diagnosis
- Initial Presentation for all patients,




(61) (31) (19) (14) (7) (11)




















































Flank or back i 49.2% 12.9% 11.1% 28.6%
























































































































































































































































































Yes No No No No No No No
No No No
Table 7 . Signs and Symptoms at Diagnosis
- Initial Presentation for ALL PATIENTS ,
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and papillary necrosis were asymptomatic at diagnosis, 23.1%
(3) had dysuria, 15.4% (2) had frequency, none had polyuria,
23.1% (3) had nocturia, 15.4% (2) had hematuria as a symptom,
33.5%(5) had flank or back pain, 15.4% had renal tenderness,
7.7% (1) had dehydration and 38,5% (5) had temperatures above
101F.
For those patients with renal papillary necrosis who smoked
cigarettes their renal function was determined and compared to
that of the non-smokers--mean serum creatinine at diagnosis:
non-smokers--l .6 mg/dl, light smokers--!. 4 mg/dl, heavy smokers-
2.4 mg/dl. For the next five years after diagnosis mean serum
creatinine ranged between 1.1 mg/dl and 1.9 mg/dl for non-
smokers, between 1.5 mg/dl and 6.0 mg/dl for light smokers and
between 1.3 mg/dl and 4.0 mg/dl for heavy smokers.
For those patients with a history of urinary tract infection,
their mean age was 42.7 years, 74.4% were females and 25.6% males;
62.8% were White, 34.9% Black, 2.3% Hispanic. Eight of the 12
patients known to be dead had urinary tract infection history.
Their mean serum creatinine at diagnosis was 2.0 mg/dl as com
pared to 1.0 mg/dl for those patients who did not have a history
of UTI. For the next five years after diagnosis their mean serum
creatinine ranged between 1.5 mg/dl and 3.1 mg/dl. At initial
presentation, 73.8% (31) had pus cells
in the urine, 16.7% (7)
had glucosuria, 47.5% (20) had proteinuria, 42.9% (18) had hema-
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turia by U/A, 76.2% (32) had bacteriuria, mean pH was 6.0
and mean specific gravity 1.014. Nineteen percent had dysuria,
21.4% had frequency, 2.4% had polyuria, 16.7% had nocturia,
26.2% had hematuria as a symptom, 54.8% had flank or back pain,
21.4% had hypertension, 38.1% had renal tenderness, 9.5% were
dehydrated and 45.2% had a temperature above 101F. Eighty-eight
percent (38) of these patients received antibiotics for treatment
at their initial presentation with papillary necrosis.
Among patients that received any treatment during initial
presentation, nine deaths are known--18.8%. From the non-treated
group three patients are known to be dead--21.4%. Mean serum
creatinine at diagnosis was 1.9 mg/dl for those who received
treatment, and 1.1 mg/dl for those that were not treated. For
those treated, mean serum creatinine at one year--2.3 mg/dl (14),
at two years 1.4 mg/dl (9), at three years--2.5 mg/dl (6), at
four years--1.6 mg/dl (4) and at five years--3.1 mg/dl (7).
The variable that ascertains certainty of diagnosis was
correlated with occurence of associated conditions: 91.8% (45)
of those whose diagnosis is said to be certain do have one or
more of the conditions known to be associated with papillary
necrosis; 76.9% (10) of those with a probable diagnosis do have
associated conditions also. A certain diagnosis was definite
documentation of the disease by X-rays and/or histology; while a
probable one lacked this documentation. The mean serum creatinine
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at diagnosis for those with a certain diagnosis was 1.9 mg/dl
while it was 1.4 mg/dl for those with a probable one. Mean
serum creatinine during the five years of follow-up was always
lower for the probable group than for the certain group.
Table 8 illustrates incidences of the different associated
conditions in the major studies in the literature. Our group




























16% 7 9% 28% 21%








- - - 6%
Renal TB 3% - - 2%




Table 8. Comparison of frequency distributions for the
different associated conditions in the major




Most of our results stand by themselves in their descriptive
importance. Let us consider first the distribution of patients
among the different associated conditions. It is indeed re
markable that 56% of our patients had more than just one condition
associated with papillary necrosis. At least two implications
are derived from this observation: l--associated conditions when
Present simultaneously may have additive effects in the pathogen
esis of the papillary lesion, presumably by further damaging the
vascular supply to the area, thus making papillary necrosis in
these patients more common than in those with only one etiologic
factor; and 2--the presence of one associated condition may pre
dispose to the occurrence of another, specifically chronic pyelo
nephritis resulting from long standing urinary tract obstruction
or diabetes mellitus. If we consider that chronic pyelonephritis
and urinary tract obstruction were found in association in 14
Patients, both of the above mentioned postulates may be correct.
Only one out of the 13 analgesic-abuse patients did not have
another associated condition. This finding supports the observa
tion that papillary necrosis caused by analgesic abuse is not as
common here as in some other countries (51). Also of interest
is the fact that only two out of 21 patients with chronic pyelo
nephritis in this study had chronic pyelonephritis as the only
associated condition, suggesting that chronic pyelonephritis may
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be secondary or simultaneous to papillary necrosis caused by
other conditions. Still, the two patients with chronic pyelo
nephritis alone agree with the case reports of papillary necrosis
where chronic pyelonephritis is the only associated condition (42).
It is important also to note that alcoholism and cirrhosis did
not present alone in any of these patients. However, one patient
had both alcoholism and cirrhosis as the only associated con
ditions to his papillary necrosis which supports Longacre's assoc
iation of cirrhosis of the liver and renal papillary necrosis (62).
When arranged from most common to least common, associated
conditions appear as follows: urinary tract obstruction, chronic
pyelonephritis, S-hemoglobin, analgesic abuse, diabetes, alcoholism,
cirrhosis and renal Tb.
The demographic data shows that the typical patient with
papillary necrosis is middle aged; females more than twice as
common as males. No ethnic group seemed to be more particularly
affected, except in the S-hemoglobin patients who were 100% Black.
It is interesting to note that the youngest (10 y.o.) and the
oldest (82 y.o.) patients both had urinary tract obstruction and
chronic pyelonephritis which suggests that papillary necrosis can
occur in this setting at any age. The analgesic abuse patients
were mostly White females, an observation that agrees with other
reports in the literature (39). The oldest subgroup
of patients
was the adult-onset diabetes with a mean age of 56.1 years (16
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years above the mean age for all patients), which correlates well
with the higher mortality of diabetics in this study.
Most commonly, diagnosis was arrived at with intravenous
pyelography, which reflects the utility of this radiographic exam
in the search of this disease. The fact that none of our patients
were diagnosed by observing tissue passed in the urine implies
that either it is not a common feature (in fact only one of our
patients passed some papillary tissue in the urine) or that strain
ing the urine of these patients is not a most suitable way for
arriving at diagnosis.
Unilateral involvement was found to be twice as common as
disease in both kidneys. The S-hemoglobin patients, however,
were distributed equally between unilateral and bilateral in
volvement. Why unilateral involvement is more common and why do
some patients have unilateral and others bilateral disease, we
can not explain.
At least 19% of all patients are known to be dead after a
mean of 5.2 years of follow-up after initial presentation. Not
surprisingly, half of the patients who died were diabetics. This
observation agrees with the reports in the literature that attribute
a bad prognosis to diabetes when associated with papillary necrosis
(1,39,88). Fifty-four percent of our diabetic patients are known
to be dead after a mean of 6.4 years of follow-up after diagnosis,
which makes this group the highest in mortality. In interpreting




this group of patients was also the oldest of all groups, and
secondly, the pathology of such kidneys may include other renal
injuries such as glomerulosclerosis and chronic pyelonephritis
as well (88).
We were not able to do a survivalship table since we did
not have available all the information it takes to make one,
specifically the dates of death for all patients who died. Our
mortality numbers reflect only a minimum of patients known to be
dead, and the assumption that all other patients are still alive
can not be guaranteed since our attempt to update follow-up on
all live patients did not have a satisfactory yield. With this
in mind, Table 2 implies that short term prognosis of renal pap
illary necrosis may be generally benign for all associated con
ditions except for diabetes, which we have already discussed.
When cause of death was determined, extrarenal causes like cerebro
vascular accidents and myocardial infarction were most commonly
found (in fact, we know of only one patient who died
in severe
renal failure).
Determination of renal function was made by means of the
serum creatinine values where 1.5 mg/dl was defined as upper
limit
of normal. At the time of diagnosis of papillary necrosis, most
patients in our group did not have any degree
of renal insufficiency
(median
= 1.4 mg/dl, 61% of all patients had serum creatinines
of
1.5 mg/dl or less) even when mean serum creatinine
was 1.8 mg/dl.




unchanged but the number of patients who had such determination
decreased by more than one half. Unfortunately, when we look
throughout Table 3 for information on the renal function of these
patients, we find that number of patients followed with serum
creatinines decreased considerably with time. Apparently, only
those patients with serious problems or elevated creatinines had
their renal function evaluated. As a result of this, the sample
of patients is extremely biased and we don't believe we can reach
at any further conclusion about renal function from this data.
It is interesting to note that 62% of all patients had
Pyuria at initial presentation; the associated condition in
which it was most common was diabetes (80%), very closely followed
by the chronic pyelonephritis patients (76%). Pyuria was defined
as more than 5wbc's/HPF. Among the patients who had urinalysis
in the next five years, pyuria persisted as a fairly common find
ing. Our renal Tb patient did not have sterile pyuria, but in
stead had bacteriuria and no pus cells in the urine. She did
not have a bacterial infection and was asymptomatic at diagnosis.
Only 11.5% of all patients had glucosuria (>_1 + ) and this
finding was most common among diabetics (60%). Forty-one percent
of all patients had proteinuria (more than trace) at diagnosis,
and diabetes again was the associated condition in which it was
most common (60%) closely followed by chronic pyelonephritis (52%)
and UT obstruction (48%). Once again, among the patients who had
further U/A's, proteinuria was noted to persist as a common finding.
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Interestingly, hematuria (>5 rbc's/HPF) was noted in 41% of
all patients and all associated conditions seemed about equally
affected with this finding, with the exception of our renal Tb
patient who did not present with hematuria. A general trend of
decrease in number of patients with hematuria can be observed in
the years of follow-up, particularly the drop from 41% at diagnosis
to 18% one year later. This drop in number of patients with
hematuria at follow-up is certainly reassuring.
Bacteriuria (any bacteria/HPF) was observed in 75% of all
patients at diagnosis. It was a common finding in all the associ
ated conditions and persisted throughout follow-up.
Mean specific gravity for all patients was 1.015, exactly
the value we defined beforehand as the lower limit of adequate
concentration ability. Since we do not know the hydration status
of these patients (except that 7% of them were clinically dehy
drated at initial presentation) we cannot say anything definite
about their concentration ability. However, we can note that
most patients (62%) had specific gravities less than or equal to
1.015 at diagnosis and that the mean SG did not change during
follow-up. This trend was most obvious in the S-hemoglobin
patients who had a mean SG at diagnosis of 1.012, which agrees
with observations made in the literature (83). No significant
aberrations were noted in the mean pH values for all patients
and all groups of patients.
Almost one fourth of all patients were asymptomatic during
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initial presentation, an interesting finding which suggests
that the clinical picture of this disease can be silent at least
until complications from the papillary necrosis occur. If we
consider that our patient selection was in itself a biased pro
cedure since only patients who seeked medical attention make our
entire group, we must realize that papillary necrosis might very
well be common in its undiagnosed, uncomplicated form. Interestingly
enough, none of our analgesic abusers were asymptomatic.
As can be seen in Table 6, the proportion of patients with
signs and symptoms including dysuria, frequency, polyuria, nocturia,
hematuria, flank or back pain, hypertension, renal tenderness, de
hydration and fever, did fall substantially during follow-up. This
may speak in favor of a good prognosis for most patients in terms
of signs and symptoms. Interestingly, 36% of patients seen five
years after diagnosis had flank or back pain and 27% had renal
tenderness. These were the clinical signs most salient at five
years (when only 11 out of the 62 patients were seen) which in
dicate an acute renal presentation for the affected patients.
During initial presentation, flank or back pain was the
most common symptom (49%) and 38% had a temperature equal or
greater than 101F, again indicating an acute presentation.
Gross
hematuria was the third most common symptom (33%). The difference
between hematuria observed by U/A and hematuria recorded as a
symptom gives us an indication
of the patients with microscopic
hematuria
= five patients or 8%.

-53-
Polyuria was a most rare symptom--only two patients and at
least one was a diabetic.
Thirteen out of 18 patients with renal tenderness and 14 out
of the 19 patients with temperatures of 101F or above had urinary
tract obstruction, an observation that seems to link the acute pre
sentation of the disease with this associated condition.
Only 21% of all patients were found to have diastolic
pressures of 90 mmHg or above so we are unable to suggest a strong
association between papillary necrosis and elevated blood pressure.
Interestinly, 85% of the hypertensive patients had had a urinary
tract infection at some time. They also had a greater degree of
renal insufficiency at diagnosis than the normotensive group. How
ever, the fact that only one of the patients known to be dead had
hypertension (and died of an extrarenal cause), and the observation
that mean serum creatinines ranged in between 1.2 mg/dl and 1.4 mg/dl
for the next four years after diagnosis suggest that hypertension
does not carry bad prognostic implications when it occurs together
with papillary necrosis. From our data we could not determine
if
hypertension was a consequence of papillary necrosis or merely
simultaneous. However, the fact that its frequency fell from 18%
to 6% one year after diagnosis when we still had a considerable
number of patients, seems to indicate that it is more a part of
the acute or initial presentation when the patient is symptomatic.
Their substantial fall in mean serum creatinine also
indicates that




panied by acute obstruction or infection.
For the 53% of patients who smoked cigarettes, their initial
renal function was found to be slightly worse than that of non-
smokers. Heavy smokers did have a substantially elevated mean
serum creatinine (2.4) at diagnosis when compared to that of the
non-smokers (1.6). This suggests that cigarette smoking may be
related to decreased renal function in this setting; and in gen
eral , smokers had greater values for mean serum creatinines dur
ing follow-up.
In agreement with those investigators who found infection to
be a common denominator among most patients with papillary
necrosis (28,56,57), we found a strong association between renal
papillary necrosis and history of urinary tract infection. Sixty-
nine percent of our patients had had a urinary tract infection at
some time and 47% of them were actually infected at initial presenta
tion. Their mean serum creatine at diagnosis was twice the value
for those who did not have a history of infection, and most
significantly eight of the 12 dead patients had a urinary
tract infection
history. Not only does infection seem to be very common among
papillary necrosis patients, but the
data also suggests that it
may worsen the prognosis of the disease.
Seventy-seven percent of patients received some type
of treat
ment for their papillary necrosis during initial presentation and
among them nine deaths
are known (19%). A similar frequency dis




indicates that treatment did not make much of a difference in
the mortality of this disease, which is not unexpected since





More than half of the patients in this study had more than
just one associated condition to their papillary necrosis. These
conditions appeared associated with papillary necrosis in the
following order of frequency: urinary tract obstruction, chronic
pyelonephritis, S-hemoglobin, analgesic abuse, diabetes, alcohol
ism, idiopathic, cirrhosis and renal tuberculosis. Intravenous
pyelography was still the most common way of arriving at diagnosis.
Finding of papillary tissue in the urine was a rare feature and
probably not a suitable means of diagnosis. Unilateral involve
ment was twice as common as bilateral disease in our patients.
Short term prognosis of renal papillary necrosis in terms
of mortality may be generally benign for all groups except for
diabetics, who also were the oldest group. At initial presentation,
most patients did not have any degree of renal insufficiency.
One year after diagnosis, mean serum creatinine remained basically
unchanged. Any other conclusions about renal function
in the next
five years cannot be made because
of inadequate follow-up.
Pyuria and proteinuria were common findings
for all patients
but more commonly for diabetics and patients with chronic pyelo
nephritis. These findings
both persisted throught the five years
of follow-up. Hematuria (by U/A) was common in
all condiitons ex
cept renal Tb (one patient) and
its frequency fell considerably
after initial presentation. Microscopic
bacteriuria was common in
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all conditions and persisted throughout follow-up.
One fourth of all patients were asymptomatic at diagnosis.
Frequency of signs and symptoms among all patients fell sub
stantially during follow-up suggesting good prognostic implications.
Dysuria and frequency were most common among the analgesic abuse
group. Flank or back pain, fever and gross hematuria were the
most common signs and symptoms for all patients which point to
wards an acute presentation. Most of the patients with renal ten
derness and fever had urinary tract obstruction which links the
acute presentation with this associated condition.
Hypertension was not found in strong association to renal
papillary necrosis and does not carry serious prognostic implica
tions. High blood pressure is probably part of the acute or
initial presentation when the patienfis symptomatic.
A strong association was found between infection and renal
papillary necrosis. History of urinary tract infection is an
isolated variable that appears to worsen prognosis. Treatment
did not make much of a difference in mortality of this disease.
Perhaps the most important conclusion of this study
is the
realization that nothing definite can be said about prognosis and
natural history of this disease until a prospective study
is done.
We have only presented data on the clinical features
and short term
follow-up of these patients with the
limitations that accompany




function, U/A findings and signs and symptoms make us believe
that renal papillary necrosis is not such a bad disease after
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